Michael J Hall

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. ncbi Barriers to participation in cancer prevention clinical trials
    Michael J Hall
    Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Acta Oncol 49:757-66. 2010
  2. ncbi BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer
    Michael J Hall
    Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
    Cancer 115:2222-33. 2009
  3. ncbi Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
    Michael J Hall
    Medical Oncology and Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Natl Compr Canc Netw 8:606-11. 2010
  4. ncbi Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing
    Michael J Hall
    Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Cancer Epidemiol Biomarkers Prev 20:249-54. 2011
  5. ncbi Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing
    Michael J Hall
    Medical Oncology and Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Cancer Prev Res (Phila) 3:1579-85. 2010
  6. ncbi Significance of pathologic response to preoperative therapy in pancreatic cancer
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Ann Surg Oncol 18:3601-7. 2011
  7. ncbi Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer
    Andrea D Forman
    Familial Risk Assessment Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Breast J 15:S56-62. 2009
  8. ncbi Family history of pancreatic cancer in a high-risk cancer clinic: implications for risk assessment
    Michael J Hall
    Department of Medicine, Columbia University College of Physicians and Surgeons, Mailman School of Public Health, New York, NY 10032, USA
    J Genet Couns 17:365-72. 2008
  9. ncbi Interpretation of genetic testing for lynch syndrome in patients with putative familial colorectal cancer
    Christina Rybak
    Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA
    J Natl Compr Canc Netw 9:1311-20. 2011
  10. ncbi Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program
    Michael J Hall
    Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer 118:478-84. 2012

Detail Information

Publications13

  1. ncbi Barriers to participation in cancer prevention clinical trials
    Michael J Hall
    Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Acta Oncol 49:757-66. 2010
    ..We sought to characterize barriers to prevention trial participation among medical oncologists and first-degree relatives of their patients...
  2. ncbi BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer
    Michael J Hall
    Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
    Cancer 115:2222-33. 2009
    ..In this study, the authors examined the prevalence of BRCA1 and BRCA2 mutations in an ethnically diverse group of women who were referred for genetic testing...
  3. ncbi Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
    Michael J Hall
    Medical Oncology and Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Natl Compr Canc Netw 8:606-11. 2010
    ..Data supporting clinical efficacy (feasibility) and effectiveness (real-life performance) are critical before important policy changes are adopted, especially where issues of hereditary cancer risk and genetic privacy are involved...
  4. ncbi Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing
    Michael J Hall
    Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Cancer Epidemiol Biomarkers Prev 20:249-54. 2011
    ....
  5. ncbi Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing
    Michael J Hall
    Medical Oncology and Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Cancer Prev Res (Phila) 3:1579-85. 2010
    ....
  6. ncbi Significance of pathologic response to preoperative therapy in pancreatic cancer
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Ann Surg Oncol 18:3601-7. 2011
    ..Pathologic response to preoperative therapy is increasingly recognized as an important prognostic factor in solid tumors. The impact of pathologic response on survival in pancreatic adenocarcinoma is not well established...
  7. ncbi Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer
    Andrea D Forman
    Familial Risk Assessment Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Breast J 15:S56-62. 2009
    ..g., medical mistrust, perceived disadvantages to genetic services), as well as additional barriers to care once mutation carriers are identified, will be reviewed...
  8. ncbi Family history of pancreatic cancer in a high-risk cancer clinic: implications for risk assessment
    Michael J Hall
    Department of Medicine, Columbia University College of Physicians and Surgeons, Mailman School of Public Health, New York, NY 10032, USA
    J Genet Couns 17:365-72. 2008
    ..In risk assessment for HBOS, identifying a family history of PC should strongly raise the suspicion of an unrecognized BRCA1/2 mutation...
  9. ncbi Interpretation of genetic testing for lynch syndrome in patients with putative familial colorectal cancer
    Christina Rybak
    Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA
    J Natl Compr Canc Netw 9:1311-20. 2011
    ..This article reviews important clinical features of LS genetic evaluation using 3 pedigree-based case examples from the Fox Chase Cancer Center Gastrointestinal Risk Assessment Clinic...
  10. ncbi Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program
    Michael J Hall
    Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer 118:478-84. 2012
    ..If present, such disparities could support hypotheses for further research examining racial differences in awareness and patient preferences in undergoing CRC screening...
  11. ncbi Defining venous involvement in borderline resectable pancreatic cancer
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Ann Surg Oncol 17:2832-8. 2010
    ..There is no consensus about what degree of venous impingement constitutes borderline resectability...
  12. ncbi Disparities in genetic testing: thinking outside the BRCA box
    Michael J Hall
    Department of Medicine, Mailman School of Public Health, Columbia University, New York, NY, USA
    J Clin Oncol 24:2197-203. 2006
    ..The importance of expanded testing in underserved populations is emphasized...
  13. ncbi Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer
    Dawn Hershman
    Department of Medicine, Mailman School of Public Health, Columbia University, New York, New York, USA
    Cancer 107:2581-8. 2006
    ..However, to the authors' knowledge, the effect of the interval between surgery and the initiation of chemotherapy on survival has not been investigated...